Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precancerous Conditions 11Neoplasms 4Stomach Neoplasms 3Rare Malignant Neoplasm 3Esophageal Neoplasms 3Colorectal Neoplasms 3Skin Diseases 2Pancreatic Neoplasms 2Obesity-Related Malignant Neoplasm 2Neoplasms by Site 2Neoplasms by Histologic Type 2Keratosis, Actinic 2Carcinoma, Non-Small-Cell Lung 2Venentoclax 1Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Tongue Neoplasms 1Syndrome 1Stomach Ulcer 1Small Cell Lung Carcinoma 1Secondary Malignant Neoplasm of Liver 1Salivary Gland Neoplasms 1Salivary Gland Malignant Neoplasms 1Rectal Malignant Neoplasms 1Preleukemia 1

Interventions

toripalimab 1potassium oxonate 1gimeracil 1apatinib 1Tegafur 1Nivolumab 1Gemcitabine 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Malignant Neoplasms of Digestive Organs × Other neoplasm × Clear all
NCT05934331 2025-09-12

A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

LaNova Medicines Limited

Phase 2 Recruiting
276 enrolled
Other neoplasm

Malignant Neoplasms of Digestive Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡